Ongoing studies into the drug are showcasing promising outcomes regarding body composition . Initially created for treating type 2 diabetes , this GLP-1 receptor agonist has indicated substantial https://socialwebleads.com/story7007963/semaglutide-research-exploring-emerging-body-shaping-opportunities